According to John Hopkins Medicine, 50 to 80 percent of U.S. adults have the oral herpes virus and many don’t know it. Most commonly associated with “cold sores” or “fever blister” the herpes virus can cause other, more serious symptoms as well. These include severe flu-like symptoms, swollen lymph nodes and headaches. The National Institutes of Health (NIH) recently awarded Afsar Naqvi, assistant professor at the University of Illinois, Chicago’s College of Dentistry, a five year, $2 million grant to study this wide spread and yet often misdiagnosed disease.Read More
Science Market Update
Tags: Bioresearch, Bioresearch funding, University of Illinois, Cannabinoids, University of Illinois Chicago, Illinois, University of Illinois at Chicago, NIH funded Research Projects, Chicago, biotech vendor show, laboratory equipment suppliers, research news, UIC, UIChgo, NIH grants, laboratory suppliers, Biologics, BioResearch Product Faire, virus research
Are you looking to get your lab products in front of researchers doing cannabis related research projects?Read More
When obstructive sleep apnea (OSA) was listed as a contributing factor in the death of actress Carrie Fisher, it brought the condition into the spotlight. Until the news, many people considered sleep apnea to be just a bothersome form of snoring. However, with OSA, breathing is actually interrupted for a few seconds or even several minutes. According to the American sleep apnea association, 38,000 people die annually from heart disease directly complicated by sleep apnea. Now researchers at the University of Illinois, Chicago (UIC) believe they have found the first medication that reduces the effects of OSA, and it's based on a molecule found in the cannabis plant.Read More
Tags: Bioresearch, Bioresearch funding, University of Illinois, Cannabinoids, University of Illinois Chicago, Illinois, University of Illinois at Chicago, clinical trials, Chicago, biotech vendor show, laboratory equipment suppliers, research news, UIC, UIChgo, laboratory suppliers, BioResearch Product Faire, cannabis research
As cannabis use becomes legal in more and more states in the US, both for recreational and medical purposes, it is becoming necessary for more research into the drug. Currently in the US, 20% of the population have access to legal recreational marijuana use and 60% have access to legal medical marijuana. Unfortunately, even with such widespread access to cannabis, research if the drug has been limited due to the DEA classifying it as a Schedule I drug in the 1970s. (Image courtesy of CC BY-SA 3.0 via Wikimedia Commons)Read More
Did you know you can be considered a "pot-head" without ever touching, let alone smoking, marijuana? When early neuroscientists went looking for the mental hardware that allowed the body to respond to the active ingredient in the cannabis sativa plant (called THC), they found much more than they were bargaining for. They did in fact identify a perfectly-shaped receptor in the brain. Puzzled at why it would exist (surely the human body was not designed with cannabis-intake in mind?), they went on to discover that the body itself makes a cannabis-like substance, called an endocannabinoid, and that it is part of a complex system regulating appetite, pain, pleasure, and immunity. So, technically, your brain is already wired for pot, and your body produces it all by itself.
Debates over the legitimacy of medical marijuana as a pain medication or appetite enhancer have tended to point to a lack of scientific studies proving the key substance is safe and effective. Patients and doctors have not always waited for that hard evidence, instead working from an empirical position that saw positive results from the ingestion of cannabinoids, the active ingredients, that lead them to make their own treatment decisions. But serious bioscience research, especially in the fields of pharmacology, infectious disease, and neuroscience, is showing surprising results in laboratory studies on cannabinoids, and those findings go far beyond the pain and appetite benefits to actually short-circuiting disease in late-stage AIDS patients.